Dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Brain : a journal of neurology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/brain/awr320PMID 22189567
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration.

  2012cited by this paper
• Age and 17β-estradiol effects on blood-brain barrier tight junction and estrogen receptor proteins in ovariectomized rats.

  2011cited by this paper
• Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats.

  2010cited by this paper
• Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.

  2010cited by this paper
• Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson’s disease

  2010cited by this paper
• Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease.

  2010cited by this paper
• Enhanced sensitivity to acute angiotensin II is testosterone dependent in adult male growth-restricted offspring.

  2010cited by this paper
• Aging enhances the neuroinflammatory response and alpha-synuclein nitration in rats.

  2010cited by this paper
• Estradiol and Testosterone Levels Are Lower after Oophorectomy than after Natural Menopause

  2009cited by this paper
• The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease

  2009influential reference
• Sex-different effect of angiotensin II type 2 receptor on ischemic brain injury and cognitive function.

  2009cited by this paper
• Disruption of the Ang II type 1 receptor promotes longevity in mice.

  2009cited by this paper
• Aging effects on the dopamine transporter expression and compensatory mechanisms.

  2009cited by this paper
• Using Basic Science to Design a Clinical Trial: Baseline Characteristics of Women Enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)

  2009cited by this paper
• Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance

  2009cited by this paper
• Coronary heart disease of females: lessons learned from nonhuman primates

  2009cited by this paper
• Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

  2008cited by this paper
• Estrogen elicits dorsal root ganglion axon sprouting via a renin-angiotensin system.

  2008cited by this paper
• Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.

  2008influential reference
• Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species.

  2008cited by this paper
• Estrogen receptor-alpha overexpression suppresses 17beta-estradiol-mediated vascular endothelial growth factor expression and activation of survival kinases.

  2008cited by this paper
• Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.

  2008cited by this paper
• Estrogen prevents intestinal inflammation after trauma-hemorrhage via downregulation of angiotensin II and angiotensin II subtype I receptor.

  2008cited by this paper
• Androgen Increases AT1a Receptor Expression in Abdominal Aortas to Promote Angiotensin II–Induced AAAs in Apolipoprotein E–Deficient Mice

  2008cited by this paper
• Estrogen and Angiotensin II Interactions Determine Cardio-Renal Damage in Dahl Salt-Sensitive Rats with Heart Failure

  2007cited by this paper
• Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression

  2007cited by this paper
• Mechanism of 6‐hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6‐hydroxydopamine‐induced degeneration of dopaminergic neurons

  2007cited by this paper
• Sex differences in angiotensin II- induced hypertension.

  2007cited by this paper
• OESTROGEN AND NIGROSTRIATAL DOPAMINERGIC NEURODEGENERATION: ANIMAL MODELS AND CLINICAL REPORTS OF PARKINSON'S DISEASE

  2007cited by this paper
• Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease.

  2007cited by this paper
• Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice.

  2007cited by this paper
• Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons.

  2007influential reference
• Ovarian androgen production in postmenopausal women.

  2007cited by this paper
• Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions

  2007influential reference
• Age-related changes in neuroprotection

  2006cited by this paper
• Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies.

  2006cited by this paper
• Implications for Estrogens in Parkinson's Disease

  2006cited by this paper
• Age at menopause predicts age at onset of Parkinson's disease

  2006influential reference
• Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.

  2006cited by this paper
• Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.

  2006influential reference
• Temporal expression of IL-1β protein and mRNA in the brain after systemic LPS injection is affected by age and estrogen

  2006cited by this paper
• Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.

  2006cited by this paper
• Inhibitory Effects of AT1 Receptor Blocker, Olmesartan, and Estrogen on Atherosclerosis Via Anti-Oxidative Stress

  2005cited by this paper
• Estrogen Reduces Angiotensin II-Induced Acceleration of Senescence in Endothelial Progenitor Cells

  2005cited by this paper
• Estrogen: A Neuroprotective or Proinflammatory Hormone? Emerging Evidence from Reproductive Aging Models

  2005cited by this paper
• Sex Difference in Vascular Injury and the Vasoprotective Effect of Valsartan Are Related to Differential AT2 Receptor Expression

  2005cited by this paper
• Pharmacokinetics and effects of 17beta-estradiol and progesterone implants in ovariectomized rats.

  2005cited by this paper
• Brain Angiotensin II: New Developments, Unanswered Questions and Therapeutic Opportunities

  2005cited by this paper
• 17beta-estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats.

  2005cited by this paper
• Estrogen Influences Cocaine-Induced Blood Oxygen Level-Dependent Signal Changes in Female Rats

  2005influential reference
• Is the Estrogen Controversy Over? Deconstructing the Women's Health Initiative Study: A Critical Evaluation of the Evidence

  2005cited by this paper
• Controversies about HRT--lessons from monkey models.

  2005cited by this paper
• Protective effect of the inhibition of the renin-angiotensin system on aging.

  2005cited by this paper
• Women, hormones, and clinical trials: a beginning, not an end.

  2005cited by this paper
• NADPH Oxidase Mediates Lipopolysaccharide-induced Neurotoxicity and Proinflammatory Gene Expression in Activated Microglia*

  2004cited by this paper
• Oxidative stress in neurodegeneration: cause or consequence?

  2004cited by this paper
• Upregulation of angiotensin II type 2 receptor expression in estrogen-induced pituitary hyperplasia.

  2004cited by this paper
• Aging of the nigrostriatal system in the squirrel monkey

  2004cited by this paper
• Hormone Therapy: Physiological Complexity Belies Therapeutic Simplicity

  2004cited by this paper
• NADPH oxidase.

  2004cited by this paper
• Postmenopausal estrogen use affects risk for Parkinson disease.

  2004cited by this paper
• Vascular Inflammation in Aging

  2004cited by this paper
• Inhibiting angiotensin receptors in the brain: possible therapeutic implications

  2003cited by this paper
• The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases.

  2003cited by this paper
• The brain renin-angiotensin system: location and physiological roles.

  2003cited by this paper
• Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease

  2003cited by this paper
• Mechanism of Endothelial Cell NADPH Oxidase Activation by Angiotensin II

  2003cited by this paper
• Estrogen regulates adrenal angiotensin type 1 receptors by modulating adrenal angiotensin levels.

  2003influential reference
• Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females.

  2003cited by this paper
• Aging‐induced proinflammatory shift in cytokine expression profile in rat coronary arteries

  2003cited by this paper
• NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

  2003influential reference
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Renin angiotensin system and gender differences in the cardiovascular system.

  2002cited by this paper
• Estrogen upregulates renal angiotensin II AT(2) receptors.

  2002cited by this paper
• Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II

  2002influential reference
• Dose-Dependent Regulation of NAD(P)H Oxidase Expression by Angiotensin II in Human Endothelial Cells: Protective Effect of Angiotensin II Type 1 Receptor Blockade in Patients With Coronary Artery Disease

  2002cited by this paper
• Angiotensin II Stimulation of NAD(P)H Oxidase Activity: Upstream Mediators

  2002cited by this paper
• Is there a connection between estrogen and Parkinson's disease?

  2002cited by this paper
• Effect of Estrogen and AT1 Receptor Blocker on Neointima Formation

  2002cited by this paper
• Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

  2002cited by this paper
• Estrogen and opioids interact to modulate the locomotor response to cocaine in the female rat.

  2002cited by this paper
• Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women

  2001cited by this paper
• Chronic estrogen treatment replaces striatal dopaminergic function in ovariectomized rats.

  2001cited by this paper
• Differential role of angiotensin II receptor subtypes on endothelial superoxide formation

  2000cited by this paper
• NADPH oxidase: an update.

  1999cited by this paper
• Gender differences in dopaminergic function in striatum and nucleus accumbens.

  1999cited by this paper
• Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5' leader sequence of the receptor mRNA.

  1999cited by this paper
• Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes.

  1998cited by this paper
• Estrogen modulates AT1 receptor gene expression in vitro and in vivo.

  1998cited by this paper
• Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine.

  1997cited by this paper
• Disposition of the new angiotensin II receptor antagonist candesartan cilexetil in rats and dogs.

  1996influential reference
• Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.

  1995cited by this paper
• Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

  1994cited by this paper
• Some new, simple and efficient stereological methods and their use in pathological research and diagnosis

  1988cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Measurement of serum steroid and gonadotropin levels and uterine and ovarian variables throughout 4 day and 5 day estrous cycles in the rat.

  1979cited by this paper
• Passage of steroids through silicone rubber.

  1966cited by this paper

• Bilateral Oophorectomy or Hysterectomy with Ovarian Conservation and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Temporal trends in Parkinson's disease among older adults in the United States from 1999 to 2020: Retrospective analysis from CDC WONDER database.

  2024cites this paper
• The role of the brain renin-angiotensin system in Parkinson´s disease

  2024cites this paper
• Neuroactive steroids and Parkinson's disease: a review of human and animal studies.

  2023cites this paper
• Impact of Sex on Neuroimmune contributions to Parkinson's disease.

  2023cites this paper
• Angiotensin blockade enhances motivational reward learning via enhancing striatal prediction error signaling and frontostriatal communication

  2023cites this paper
• Ghrelin Bridges DMV Neuropathology and GI Dysfunction in the Early Stages of Parkinson's Disease

  2022cites this paper
• Angiotensin blockade enhances motivational reward learning via enhancing ventral striatal prediction error and frontostriatal communication Authors

  2022cites this paper
• Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the Substantia Nigra of Male Rodents and Primary Mesencephalic Cultures

  2022cites this paper
• Microglial angiotensin type 2 receptors mediate sex‐specific expression of inflammatory cytokines independently of circulating estrogen

  2022cites this paper
• NADPH-Oxidase, Rho-Kinase and Autophagy Mediate the (Pro)renin-Induced Pro-Inflammatory Microglial Response and Enhancement of Dopaminergic Neuron Death

  2021cites this paper
• Possible repair mechanisms of renin-angiotensin system inhibitors, matrix metalloproteinase-9 inhibitors and protein hormones on methamphetamine-induced neurotoxicity

  2021cites this paper
• Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19

  2021cites this paper
• Estrogen deficiency and colonic function: surgical menopause and sex differences in angiotensin and dopamine receptor interaction.

  2020cites this paper
• Brain Renin–Angiotensin System at the Intersect of Physical and Cognitive Frailty

  2020cites this paper
• Telmisartan/17β-estradiol mitigated cognitive deficit in an ovariectomized rat model of Alzheimer's disease: Modulation of ACE1/ACE2 and AT1/AT2 ratio.

  2020cites this paper
• Interaction between brain angiotensin and dopaminergic systems and Parkinson's disease

  2020cites this paper
• The intracellular renin-angiotensin system: Friend or foe. Some light from the dopaminergic neurons

  2020cites this paper
• Rho kinase inhibitor fasudil reduces l‐DOPA‐induced dyskinesia in a rat model of Parkinson's disease

  2020cites this paper
• Interaction between Angiotensin Type 1, Type 2, and Mas Receptors to Regulate Adult Neurogenesis in the Brain Ventricular–Subventricular Zone

  2019cites this paper
• Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease

  2019cites this paper
• Aging-related dysregulation in enteric dopamine and angiotensin system interactions: implications for gastrointestinal dysfunction in the elderly

  2018cites this paper
• Within the Brain: The Renin Angiotensin System

  2018cites this paper
• Brain Renin–Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity

  2018cites this paper
• Aging-Related Overactivity of the Angiotensin/AT1 Axis Decreases Sirtuin 3 Levels in the Substantia Nigra, which Induces Vulnerability to Oxidative Stress and Neurodegeneration.

  2018cites this paper
• Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death

  2018cites this paper
• Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons

  2017cites this paper
• The renin angiotensin system and the brain: New developments.

  2017cites this paper
• Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration

  2017cites this paper
• Beneficial effects of Angiotensin II receptor blockers in brain disorders

  2017cites this paper
• Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans

  2017cites this paper
• The intracellular angiotensin system buffers deleterious effects of the extracellular paracrine system

  2017cites this paper
• Insulin-Like Growth Factor-1 and Neuroinflammation

  2017cites this paper
• Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration.

  2016cites this paper
• Emerging preclinical pharmacological targets for Parkinson's disease

  2016cites this paper
• Loss of angiotensin II receptor expression in dopamine neurons in Parkinson’s disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation

  2015cites this paper
• Central Infusion of Angiotensin II Type 2 Receptor Agonist Compound 21 Attenuates DOCA/NaCl-Induced Hypertension in Female Rats

  2015cites this paper
• Critical period for dopaminergic neuroprotection by hormonal replacement in menopausal rats.

  2015cites this paper
• Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats

  2015cites this paper
• Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration

  2015cites this paper
• Interaction between NADPH‐oxidase and Rho‐kinase in angiotensin II‐induced microglial activation

  2015cites this paper
• Rho Kinase and Dopaminergic Degeneration

  2015cites this paper
• Gender Differences in Age-Related Striatal Dopamine Depletion in Parkinson’s Disease

  2015cites this paper
• Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update.

  2014cites this paper
• Microglial TNF‐α mediates enhancement of dopaminergic degeneration by brain angiotensin

  2014cites this paper
• Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β.

  2014cites this paper
• The complexities of hormonal influences and risk of Parkinson's disease

  2014cites this paper
• Brain renin-angiotensin system and dopaminergic cell vulnerability

  2014cites this paper
• Aging-related dysregulation of dopamine and angiotensin receptor interaction.

  2014cites this paper
• Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA.

  2014cites this paper
• Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells.

  2013cites this paper
• Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression

  2013cites this paper
• Dopamine‐Angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease

  2013cites this paper
• A Role for the Brain RAS in Alzheimer’s and Parkinson’s Diseases

  2013cites this paper
• The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism.

  2013cites this paper
• Perinatal Nicotine Exposure and Programming of HIE Sensitive Phenotype in Neonatal Rat Brains

  2013cites this paper
• Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease.

  2013cites this paper
• Importance of the Brain Angiotensin System in Parkinson's Disease

  2012cites this paper
• Perinatal Nicotine Exposure Increases Vulnerability of Hypoxic–Ischemic Brain Injury in Neonatal Rats: Role of Angiotensin II Receptors

  2012cites this paper
• Review Article Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease

  2012cites this paper
• Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage

  2012cites this paper
• Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

  2012cites this paper
• Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease

  2012cites this paper
• Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin–angiotensin system in the nigra

  2012cites this paper
• Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors.

  2012cites this paper